UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000013894
Receipt No. R000016202
Official scientific title of the study Study of the tear secretion's function with new strip meniscometry tube: Influence of antiglaucoma eye drops to tear film and ocular surface part 2
Date of disclosure of the study information 2014/05/10
Last modified on 2018/11/09 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study of the tear secretion's function with new strip meniscometry tube: Influence of antiglaucoma eye drops to tear film and ocular surface part 2
Title of the study (Brief title) Influence of antiglaucoma eye drops to tear film and ocular surface
Region
Japan

Condition
Condition Glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the influence of antiglaucoma eye drops to tear film and ocular surface
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Examination of tear with strip meniscometry tube
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
10 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria The patients who need to check their visual field
Key exclusion criteria The patients who do not want to check the test
Target sample size 500

Research contact person
Name of lead principal investigator Tetuju Sekiryu
Organization Fukushima medical university school of medicine
Division name Department of ophthalmology
Address 1 Hikariga-oka, Fukushima City, Fukushima Prefecture 960-1295, Japan.
TEL 024-547-1111
Email sekiryu@fmu.ac.jp

Public contact
Name of contact person Sagara Hideto
Organization Marui Eye Clinic
Division name Director
Address 1-83-3, Honjinmae Haramachi-ku, Minamisouma City, Fukushima Prefecture 975-0062, Japan
TEL 0244-24-0101
Homepage URL
Email hide1234@ruby.ocn.ne.jp

Sponsor
Institute Department of ophthalmology, Fukushima medical university school of medicine
Institute
Department

Funding Source
Organization Marui Eye Clinic, Echo Electricity Co. Ltd.
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 05 Month 10 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 05 Month 05 Day
Anticipated trial start date
2014 Year 05 Month 10 Day
Last follow-up date
2018 Year 10 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information We check the amount of tear with strip meniscometry tube in glaucoma patients who have been treated with antiglaucoma eye drops.

Management information
Registered date
2014 Year 05 Month 07 Day
Last modified on
2018 Year 11 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016202